Table 2 Comparison of demographic and clinical by improvement of NIHSS with more than 30% at 7 days

Time to initiation of treatment (min), mean (SD)

172.7 (45.7)

157.7 (47.7)

0.079 ^b

Gender male, n (%)

38 (76.0%)

37 (51.4%)

0.006^a

Prior diagnostic of hypertension, n (%)

33 (66.0%)

53 (73.6%)

0.365^a

Prior diagnostic of stroke, n (%)

30 (60.0%)

25 (34.7%)

0.006^a

Prior diagnostic of diabetes mellitus, n (%)

3 (6.0%)

10 (13.9%)

0.165^a

Prior diagnostic of transient ischemic attack, n (%)

3 (6.0%)

2 (2.8%)

0.399^a

Dyslipidemia, n (%)

25 (50.0%)

32 (44.4%)

0.545^a

Atrial fibrillation, n (%)

15 (30.0%)

24 (33.3%)

0.689^a

Prior diagnostic of myocadiac infarction, n (%)

2 (4.0%)

7 (9.7%)

0.306^a

Prior diagnostic of valvopathies, n (%)

1 (2.0%)

2 (2.8%)

0.999^a

Prior anticoagulant treatment, n (%)

3 (6.0%)

3 (4.2%)

0.688^a

Prior antiplatelet therapy, n (%)

13 (26.0%)

25 (34.7%)

0.306^a

Age, mean (SD)

67.5 (12.4)

67.2 (11.9)

0.890^b

Systolic BP at admission, mean (SD)

160.2 (21.1)

151.9 (21.7)

0.037^b

Diastolic BP at admission, mean (SD)

81.1 (13.7)

79.9 (12.3)

0.615^b

No of platelets (thousands, mean (SD)

207.2 (63.8)

218.4 (57.7)

0.312^b

Hemoglobin, mean (SD)

14.1 (1.6)

13.5 (1.6)

0.055^b

Total cholesterol, mean (SD)

191.2 (46.9)

185.8 (45.5)

0.539^b

ASPECTS at admission, mean (SD)

9.2 (1.0)

9.7 (0.7)

0.008^b

INR, median (IQR)

1.0 (0.15)

1.0 (0.13)

0.138^c

Glycemia, median (IQR)

153.5 (85)

119.0 (42)

< 0.001^c

Creatinine, median (IQR)

0.9 (0.3)

0.9 (0.24)

0.313^c

Triglycerides, median (IQR)

102.5 (67)

105.0 (66)

0.855^c